CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC)

Publication | Closed Access

DOI

Citations

References

2000

Year

Everett E. Vokes, K. Leopold, James E. Herndon, Jeffrey Crawford, Micheal C. Perry, A. A. Miller, M.R Green

Lung Cancer

RadiologyHealth SciencesMedicineMetronomic TherapyBronchial NeoplasmInd CtCancer TreatmentOncologyRadiation OncologyLung CancerCalgb Study 9431Concomitant Chemoradiotherapy